Comment on:“Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: the GeroCovid Study”

CS Kow, DS Ramachandram, SS Hasan… - Drugs & Aging, 2024 - Springer
Dear Editor Polypharmacy, characterized by the concurrent use of multiple medications, is a
pervasive phenomenon in the elderly, particularly among those residing in long-term care …

Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: The GeroCovid Vax Study

C Trevisan, L Haxhiaj, A Malara, A Abbatecola… - Drugs & Aging, 2023 - Springer
Abstract Background and Objective Polypharmacy is common in older adults, particularly
among those living in long-term care facilities. This condition represents a marker of clinical …

Booster vaccination strongly enhances SARS-CoV-2-specific antibody and cellular responses in elderly residents of care homes

G Tut, T Lancaster, M Krutikov, P Sylla, D Bone… - 2021 - papers.ssrn.com
Abstract Third dose 'booster'COVID-19 vaccines can increase SARS-CoV-2 specific immune
responses and are being deployed widely to control the impact of omicron variant infection …

[HTML][HTML] Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study

C Trevisan, V Raparelli, A Malara… - Internal and Emergency …, 2023 - Springer
Despite the reported sex-related variations in the immune response to vaccination, whether
the effects of SARS-CoV-2 vaccination differ by sex is still under debate, especially …

Antibody responses after mRNA-based COVID-19 vaccination in residential older adults: implications for reopening

DA Nace, KE Kip, JW Mellors, OMP Palmer… - Journal of the American …, 2021 - Elsevier
Objective COVID-19 disproportionately impacts residents in long-term care facilities. Our
objective was to quantify the presence and magnitude of antibody response in vaccinated …

Reduced Antibody and Cellular Immune Responses Following Dual COVID-19 Vaccination Within Infection-Naïve Residents of Long-Term Care Facilities

G Tut, T Lancaster, MS Butler, D Bone, N Kaur… - 2021 - papers.ssrn.com
Background: Age and frailty are risk factors for poor clinical outcomes following SARS-CoV-
2 infection. As such, COVID-19 vaccination has been prioritised for this group but there is …

Antibody Responses in Elderly Residential Care Persons following COVID-19 mRNA Vaccination

DA Nace, KE Kip, OMP Palmer, MR Shurin, K Mulvey… - medRxiv, 2021 - medrxiv.org
Objective COVID-19 disproportionately impacts older adults residing at long-term care
facilities. Data regarding antibody response to COVID-19 vaccines in this population is …

[HTML][HTML] Increase in Chronic Medications and Polypharmacy—The Multifaceted Burden of COVID-19 Disease on Public Health Care

A Gallo, M Covino, A Lipari, S Pellegrino… - Journal of Personalized …, 2023 - mdpi.com
The long-term impact of COVID-19 disease is becoming a major global concern. In this
retrospective monocentric analysis, we included consecutive subjects admitted to our …

Previous SARS-CoV-2 infection, age, and frailty are associated with 6-month vaccine-induced anti-spike antibody titer in nursing home residents

AH Dyer, C Noonan, M McElheron, I Batten… - Journal of the American …, 2022 - Elsevier
Objectives Older nursing home residents make up the population at greatest risk of morbidity
and mortality from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

Diabetes affects antibody response to SARS-CoV-2 vaccination in older residents of long-term care facilities: data from the GeroCovid vax study

E Virgilio, C Trevisan, A Abbatecola, A Malara… - Diabetes …, 2022 - Am Diabetes Assoc
OBJECTIVE Type 2 diabetes may affect the humoral immune response after vaccination, but
data concerning coronavirus disease 19 (COVID-19) vaccines are scarce. We evaluated the …